DJIA 17,672.60 -141.38 -0.79%
NASDAQ 4,757.88 7.48 0.16%
S&P 500 2,051.82 -11.33 -0.55%
market minute promo

4.55 -0.11 (-2.36%)

REAL-TIME: Last trade at


company name or ticker

Recent Quotes

ARNA $4.55 -2.36%
1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $4.63
Previous Close $4.66
Daily Range $4.50 - $4.73
52-Week Range $3.26 - $7.58
Market Cap $1.0B
P/E Ratio -19.42
Dividend (Yield) $0.00 (0.0%)
Volume 5,285,505
Average Daily Volume 12,414,697
Current FY EPS -$0.26

Sector

Healthcare

Industry

Drugs

Arena Pharmaceuticals, Inc. (ARNA) Description

A clinical-stage biopharmaceutical company focused on discovering, developing and commercializing oral drugs in four major therapeutic areas: cardiovascular, central nervous system, inflammatory and metabolic diseases. Website: http://www.arenapharm.com/

News & Commentary

Newly Approved Weight Loss Method Works by Tricking Your Brain

What's the best way to lose weight? One company thinks it's simple: don't get hungry.

Seeking Alpha's Biotech Weekly: Salix Sale Murmurs, A Very Active CHMP, And More

Arena's Belviq Prescriptions Fall: More Publicity Is Needed

Biotech Stock Mailbag: Arena Pharma, Agenus, EnteroMedics

Arena Pharmaceuticals to Raise Fund Via Share Issuance - Analyst Blog

CNBC's Stock Pops & Drops From January 21

Belviq IMS Gains Consistent With Symphony

Mid-Afternoon Market Update: Alnylam Pharmaceuticals Drops Following Equity Offering; Insperity Shar

Mid-Afternoon Market Update: Alnylam Pharmaceuticals Drops Following Equity Offering; Insperity Shares Spike Higher

Mid-Afternoon Market Update: Alnylam Pharmaceuticals Drops Following Equity Offering; Insperity Shar

Mid-Afternoon Market Update: Alnylam Pharmaceuticals Drops Following Equity Offering; Insperity Shares Spike Higher

Arena's Sales Pace For Belviq - What Is Needed

See More ARNA News...

ARNA's Top Competitors

ARNA $4.55 (-2.36%)
Current stock: ARNA
AMGN $159.81 (0.15%)
Current stock: AMGN
GILD $105.54 (0.38%)
Current stock: GILD
BIIB $357.63 (1.13%)
Current stock: BIIB